ScienceDaily (Jan. 5, 2007) — The genetic code for a virulent strain of Marek's disease virus was cracked a few years ago. Now, to determine how best to cripple it and other infectious strains, Agricultural Research Service (ARS) scientists are working to decipher the genomes of several nonvirulent Marek's disease (MDV) vaccine strains.

Microbiologists Stephen Spatz at the ARS Southeast Poultry Research Laboratory in Athens, Ga., and Robert Silva at the ARS Avian Disease and Oncology Laboratory in East Lansing, Mich., have teamed up to compare nonvirulent MDV strains used in vaccines.

Marek's disease is the first cancer-causing virus for which a tumor-preventing vaccine was developed. In the United States, most commercial chickens are vaccinated against Marek's disease virus type 1 (MDV1) while inside the egg. In Europe, chicks are vaccinated when they are one day old. While these very successful vaccination programs, begun in the 1960s, have saved the industry billions of dollars, the MDV problem still persists.

That's because selective pressures imposed on the virus in vaccinated birds cause new variants to evolve that could pose a threat to the poultry industry. Because the virus is constantly evolving, new vaccines have to be developed to keep them in check.

To investigate the differences between the variants, Spatz and Silva initiated a comparative genomics research program. It involves determining the DNA sequences of various strains of MDV. Some of these are nonvirulent ones used as commercial vaccines, while others cause severe disease in chickens. By examining the differences between these strains at the DNA level, the two researchers hope to identify the genes involved in virulence--that is, the virus' ability to cause disease.

Once these genes have been identified, improved vaccines containing modifications in the virulence genes can be engineered and used to protect chickens against current disease-causing MDV strains, as well as against future strains.

ARS is the U.S. Department of Agriculture's principal scientific research agency.

The scientists' strategy for developing better vaccines for Marek's disease is to incorporate modified versions of yet-to-be identified genes important to the virus' ability to cause disease. (Photo by Stephen Ausmus)

Related Stories

Producing Flu Vaccines Will Be Faster And Cheaper, Thanks To MSU Technology (July 10, 2006) — Technology from Michigan State University animal science labs looks to produce new human flu vaccines quicker and cheaper than current methods. While studying new techniques to produce vaccines ...  > read more

Salmonella Strain's Path To Virulence Uncovered (Apr. 24, 2009) — Scientists have uncovered genetic evidence about the evolutionary path that transformed Salmonella enteritidis from an innocuous bacterium into a virulent ...  > read more

Cattle Vaccine: Brucella Abortus S19 Genome Sequenced; Points Toward Virulence Genes (June 5, 2008) — Researchers have sequenced the genome of Brucella abortus strain S19, which is used as a vaccine that protects cattle against brucellosis -- an important development because it may hold the secret as ...  > read more

In-shell Vaccine For Chick Disease (Jan. 8, 2007) — Infectious bronchitis virus causes devastating losses to the poultry industry but scientists are now developing a new way to vaccinate chicks against the disease -- one that can be delivered while ...  > read more

Search ScienceDaily

Faster Flu Vaccine